Breanna O'Reilly

Breanna O'Reilly is currently an Analyst at RA Capital Management, L.P., and a Board Observer at both Indapta Therapeutics and CellCentric. They previously held roles as a Senior Associate and Associate at RA Capital Management and were a Postdoctoral Associate at the Howard Hughes Medical Institute. Breanna earned a Doctor of Philosophy in Bioengineering and Biomedical Engineering from Boston University, where they were also a graduate student from 2017 to 2022. Prior to that, they received a Bachelor of Science in Biomedical Engineering from the University of Rochester.